Your browser doesn't support javascript.
loading
A Brief Report of Durvalumab With or Without Tremelimumab in Combination With Chemotherapy as First-Line Therapy for Metastatic Non-Small-Cell Lung Cancer: Outcomes by Tumor PD-L1 Expression in the Phase 3 POSEIDON Study.
Garon, Edward B; Cho, Byoung Chul; Luft, Alexander; Alatorre-Alexander, Jorge; Geater, Sarayut Lucien; Trukhin, Dmytro; Kim, Sang-We; Ursol, Grygorii; Hussein, Maen; Lim, Farah Louise; Yang, Cheng-Ta; Araujo, Luiz Henrique; Saito, Haruhiro; Reinmuth, Niels; Kohlmann, Milena; Lowery, Caitlin; Mann, Helen; Peters, Solange; Mok, Tony S; Johnson, Melissa L.
Afiliação
  • Garon EB; David Geffen School of Medicine at UCLA, Los Angeles, CA. Electronic address: egaron@mednet.ucla.edu.
  • Cho BC; Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea.
  • Luft A; Leningrad Regional Clinical Hospital, St Petersburg, Russia.
  • Alatorre-Alexander J; Health Pharma Professional Research, Mexico City, Mexico.
  • Geater SL; Prince of Songkla University, Songkhla, Thailand.
  • Trukhin D; Odessa Regional Oncological Dispensary, Odessa, Ukraine.
  • Kim SW; Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Ursol G; Acinus, Kropyvnytskyi, Ukraine.
  • Hussein M; Florida Cancer Specialists - Sarah Cannon Research Institute, Leesburg, FL.
  • Lim FL; Queen Mary University of London, London, United Kingdom.
  • Yang CT; Chang Gung Memorial Hospital, Taoyuan City, Taiwan.
  • Araujo LH; Instituto Nacional de Cancer-INCA, Rio de Janeiro, Brazil.
  • Saito H; Kanagawa Cancer Center, Yokohama, Japan.
  • Reinmuth N; Asklepios Lung Clinic, Member of the German Center for Lung Research (DZL), Munich-Gauting, Germany.
  • Kohlmann M; AstraZeneca, Gaithersburg, MD.
  • Lowery C; AstraZeneca, Gaithersburg, MD.
  • Mann H; AstraZeneca, Cambridge, United Kingdom.
  • Peters S; Centre Hospitalier Universitaire Vaudois, Lausanne University, Lausanne, Switzerland.
  • Mok TS; Chinese University of Hong Kong, Hong Kong, China.
  • Johnson ML; Sarah Cannon Research Institute, Tennessee Oncology, PLLC, Nashville, TN.
Clin Lung Cancer ; 25(3): 266-273.e5, 2024 May.
Article em En | MEDLINE | ID: mdl-38584069
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Pulmonar de Células não Pequenas / Anticorpos Monoclonais Humanizados / Antígeno B7-H1 / Neoplasias Pulmonares / Anticorpos Monoclonais Limite: Female / Humans / Male Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Pulmonar de Células não Pequenas / Anticorpos Monoclonais Humanizados / Antígeno B7-H1 / Neoplasias Pulmonares / Anticorpos Monoclonais Limite: Female / Humans / Male Idioma: En Ano de publicação: 2024 Tipo de documento: Article